Denmark· DK-28106042817
Synacthen
A tetracosactide product containing tetracosactid, registered in Denmark by CD Pharmaceuticals AB. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Tetracosactide is registered in 10 of 19 countries.
Countries holding a registration under ATC H01AA02 (tetracosactide), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Tetracosactide · ATC H01AA02
10 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Tetracosactid
- Manufacturer
- CD Pharmaceuticals AB
- Country
- Denmark (DK)
- ATC code
- H01AA02
- ATC class
- Tetracosactide
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106042817
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
295 interactions on record for tetracosactide.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tetracosactide · interactions on record
295 records
- 29 severe
- 246 moderate
- 20 minor
Most severe, free to view
- DesirudinB01AE01severe
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Liquid paraffinA06AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under H01AA02
Tetracosactide, as other registers publish it.
- CanadaCORTROSYN INJ 0.25MGAMPHASTAR PHARMACEUTICALS, INC.
- FinlandS-CortrophinN.V. Organon
- FinlandS-Cortrophin DepotN.V. Organon
- FinlandS-Cortrophin DepotN.V. Organon
- NorwaySynacthenAlfasigma S.p.A
- DenmarkSynacthenAlfasigma S.p.A
- NetherlandsSynacthen 0,25 mg/ml, oplossing voor injectie of infusieAlfasigma S.p.A.
- BelgiumSynacthen 0.25 mg/mlAlfasigma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf136e13-b766-487f-83dd-cc9496772e99 GET /v1/drugs/cf136e13-b766-487f-83dd-cc9496772e99?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "0,25 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28106042817",
"substance": "Tetracosactid",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "43265"
}See everything about tetracosactide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.